Selective ultrasound screening for developmental hip dysplasia: effect on management and late detected cases. A

Lene Bjerke Laborie1, Trond Jacob Markestad, Henrik Davidsen

  • 1Department of Clinical Medicine, University of Bergen, Bergen, Norway, lene.bjerke.laborie@helse-bergen.no.

Pediatric Radiology
|December 17, 2013
PubMed

Insights

Selective ultrasound (US) screening for developmental dysplasia of the hip (DDH) in at-risk infants led to early treatment and low rates of late-diagnosed hip dislocations. This approach proved effective in managing DDH, with minimal cases requiring later intervention.

Area of Science:

  • Pediatric Orthopedics
  • Diagnostic Imaging
  • Public Health Screening

Background:

  • Early intervention is crucial for developmental dysplasia of the hip (DDH).
  • Debate exists regarding the optimal screening strategy for DDH.
  • Selective screening aims to identify infants at higher risk.

Purpose of the Study:

  • To evaluate the effectiveness of a selective ultrasound (US) screening program for DDH.
  • To assess treatment outcomes and rates of late-diagnosed DDH.

Main Methods:

  • A selective US screening program was implemented for at-risk newborns (1991-2006).
  • At-risk criteria included clinical instability, breech presentation, foot deformities, or family history.
  • Infants underwent US screening within 1-3 days of birth; treatment or follow-up was based on findings.

Main Results:

  • Of 81,564 newborns, 11,539 were identified as at-risk.
  • 3.0% received early treatment, while 3.3% normalized spontaneously.
  • Late subluxated/dislocated hips occurred in 0.32 per 1,000 infants; surgical treatment was needed for 0.38 per 1,000.

Conclusions:

  • A standardized selective US screening program for DDH is effective.
  • The program achieved acceptable rates of early treatment and follow-ups.
  • Low rates of late subluxated/dislocated hips were observed compared to other studies.
Abstract

Related Concept Videos